SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were featured in successful telesurgeries during two international medical conferences in October 2026. The demonstrations underscore the growing viability of remote robotic surgery and its potential to reshape how specialized care is delivered across geographies.
At the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted cardiac procedure remotely on a patient in Bengaluru, India, approximately 7,500 miles away. At the Society of Robotic Surgery India (SRS India) Conference in New Delhi, four surgeons completed four separate robotic-assisted telesurgeries involving kidney, colorectal, pediatric urological and gynecological procedures. The SSi MantrAsana console is designed to enable real-time remote surgery through ultra-low latency connectivity, high-definition visualization and precise instrument control. As of Oct. 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system. For full details, see the full press release.
The implications for healthcare are significant. Telesurgery could allow expert surgeons to operate on patients in underserved or remote regions without travel, potentially reducing delays and improving access to complex procedures. The successful cardiac telesurgery across continents suggests that latency and control challenges are being addressed, which may accelerate adoption of remote surgical programs globally. For investors, the announcements position SS Innovations in the emerging telesurgery market. The company’s SSi Mantra system is a modular, multi-arm platform with 3 to 5 robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and the ability to superimpose 3D models of diagnostic imaging. It utilizes over 40 different types of robotic endo-surgical instruments, including 5mm instruments for pediatric and ENT surgeries, and has been clinically validated in India in more than 190 different types of surgical procedures.
SS Innovations, headquartered in India but a U.S. company, aims to make robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes the SSi Mantra system and the SSi Mudra surgical instruments. More information is available on the company’s ssinnovations.com website and LinkedIn page. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII. The announcement was distributed via TechMediaWire, a specialized communications platform focused on pioneering public and private companies driving the future of technology, which is part of the Dynamic Brand Portfolio at IBN. TechMediaWire provides access to wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, and social media distribution among other services. Full terms of use and disclaimers are available at https://www.TechMediaWire.com/Disclaimer.
